For neuraminidase-targeted antibodies triggered during infection it has been anecdotally shown for N9, that monoclonal antibodies derived from such patients may be even cross-reactive across subtypes55 and animal models have indeed shown protection against the heterologous challenge from the same NA subtype56. The gene discussed is XK; the disease is infection.